Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
Genzui Setsu, Megumi Goto, Kentaro Ito, Tomoe Taira, Masaya Miyamoto, Tomohiro Watanabe, Toru Taniguchi, Yuma Umezaki, Yusuke Nakazawa, Shuhei Uesugi, Kazuki Mori, Takao Horiuchi, Wataru Obuchi, Masako Minami, Takashi Shimada, Chisa Wada, Takanori Yoshida, Saito Higuchi
Topics & Concepts
ImmunotherapyCancer immunotherapyImmune systemBiologyT cellCancer researchCancerTumor microenvironmentCytokineImmune checkpointCancer cellPharmacologyImmunologyGeneticsCancer Cells and MetastasisMelanoma and MAPK PathwaysColorectal Cancer Treatments and Studies